Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Akin

Showing results (51-60 of 203) with videos related to

Pageof 21
Sort By:
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Blood|December 30, 2016
Mastocytosis: 2016 updated WHO classification and novel emerging treatment conceptsPeter Valent, Cem Akin, Dean D Metcalfe
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2020
Idiopathic Anaphylaxis: A Form of Mast Cell Activation SyndromeMatthew P Giannetti, Cem Akin, Mariana Castells
The New England Journal of Medicine|November 5, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2024
Demographics, Types of Patient-Reported Allergic Diseases, and Anaphylaxis in Mastocytosis: A Single-Center US ExperienceRayan N Kaakati, Dilawar Khokhar, Cem Akin
The New England Journal of Medicine|July 9, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
Leukemia Research|June 7, 2011
Tyrosine kinase inhibitors in the treatment of systemic mastocytosisCelalettin Ustun, David L DeRemer, Cem Akin
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic MastocytosisTheo Gülen, Christopher Ljung, Gunnar Nilsson, et al.
Expert Opinion on Pharmacotherapy|September 19, 2013
Mastocytosis: update on pharmacotherapy and future directionsJuan Carlos Cardet, Cem Akin, Min Jung Lee
Allergy|July 16, 2019
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protectionJesper Jarkvist, Clara Salehi, Cem Akin, et al.
Pageof 21

Showing results (51-60 of 203) with videos related to

Sort By:
Pageof 21
Blood|September 22, 2010
How I treat patients with advanced systemic mastocytosisPeter Valent, Wolfgang R Sperr, Cem Akin
Blood|December 30, 2016
Mastocytosis: 2016 updated WHO classification and novel emerging treatment conceptsPeter Valent, Cem Akin, Dean D Metcalfe
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2020
Idiopathic Anaphylaxis: A Form of Mast Cell Activation SyndromeMatthew P Giannetti, Cem Akin, Mariana Castells
The New England Journal of Medicine|November 5, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
The Journal of Allergy and Clinical Immunology. in Practice|November 8, 2024
Demographics, Types of Patient-Reported Allergic Diseases, and Anaphylaxis in Mastocytosis: A Single-Center US ExperienceRayan N Kaakati, Dilawar Khokhar, Cem Akin
The New England Journal of Medicine|July 9, 2015
Mast Cells, Mastocytosis, and Related DisordersTheoharis C Theoharides, Peter Valent, Cem Akin
Leukemia Research|June 7, 2011
Tyrosine kinase inhibitors in the treatment of systemic mastocytosisCelalettin Ustun, David L DeRemer, Cem Akin
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic MastocytosisTheo Gülen, Christopher Ljung, Gunnar Nilsson, et al.
Expert Opinion on Pharmacotherapy|September 19, 2013
Mastocytosis: update on pharmacotherapy and future directionsJuan Carlos Cardet, Cem Akin, Min Jung Lee
Allergy|July 16, 2019
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protectionJesper Jarkvist, Clara Salehi, Cem Akin, et al.
Pageof 21